Unichem Laboratories Ltd

Stage 3 · Topping · week 1

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. More about the company

₹531.1
+0.04% today
₹3,739 Cr · Small cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dPharmaceuticals 51.3%-0.4 pts
Loading price chart…
vs 52W High
-18.4%
₹284.1 lo₹650.6 hi
18.4% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 1
1w13w26w
Week 1 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
21.9%
200 DMA: ₹435.8 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.27x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -1.1% vs MA50 -1.0%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-4.4%
3M
-16.9%
6M
+61.3%
YTD
+17.7%
1Y
+10.1%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
51.3%
20d Δ
-0.4pp
1M return
-4.2%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Industry has 58 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 20w
S2 31w
S2 21w
S4 15w
S4 40w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 20w → S3 1w → S2 31w → S3 6w → S2 21w → S3 12w → S4 15w → S1 3w → S4 40w → S1 7w → S2 13w → S3 1w current
Total tracked: 169 weeks across 12 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
Pullback Hunter
Latest: 2026-08-21
Breakout Watch
Latest: 2026-07-10
46 appearances in last 60 days. First seen: 2024-08-20.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S3
Wk 1 · Vol 0.27x
2026-10-08S32→3
Wk 1 · Vol 0.59x
2026-10-07S2
Wk 13 · Vol 0.16x
2026-10-06S2
Wk 13 · Vol 0.22x
2026-10-05S2
Wk 12 · Vol 0.42x
2026-10-01S2
Wk 12 · Vol 0.36x
2026-09-30S2
Wk 12 · Vol 0.78x
2026-09-29S2
Wk 12 · Vol 20.60x
2026-09-28S2
Wk 12 · Vol 0.58x
2026-09-25S2
Wk 11 · Vol 0.25x
2026-09-24S2
Wk 11 · Vol 0.75x
2026-09-23S2
Wk 11 · Vol 1.41x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹536
200 DMA
₹435.8
52W High
₹650.6
52W Low
₹284.1
5D Low
₹530.9
Resistance levels (recent highs)
20d High
₹573.2
60d High
₹604.9
120d High
₹650.6
250d High
₹650.6
Next resistance
+7.9%
to 20d High
Ask the Market AI about UNICHEMLABAsk →
P/E (TTM)
8.5
Forward —
Earnings Growth (YoY)
-79.3%
Revenue +1.9%
ROE
+9.8%
Profit margin +11.2%
About this companyHealth Care· Pharmaceuticals

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.